VPS36: ESCRT-II Subunit in Endosomal Sorting and Cancer

Explore the VPS36 gene, its role in the ESCRT pathway, associated diseases, expression patterns, and mutations.

Gene Information Card

Symbol VPS36
Full Name VPS36 subunit of ESCRT-II
Gene Type protein-coding
Chromosomal Location 13q14.3
NCBI Gene ID 51028 ncbi.nlm.nih.gov/gene/51028
Ensembl ID ENSG00000102547
UniProt ID Q86VN1
OMIM ID 610903
HGNC ID 24948
Aliases C13orf9, CGI-145, ESCRT-II complex subunit VPS36

Description

VPS36 encodes a subunit of the endosomal sorting complex required for transport II (ESCRT-II), which is essential for sorting ubiquitinated membrane proteins into multivesicular bodies for lysosomal degradation. The protein contains a GLUE domain that binds ubiquitin and phosphoinositides, facilitating cargo recognition. VPS36 is involved in cytokinesis, autophagy, and HIV-1 budding. Mutations and altered expression have been linked to various cancers and neurological disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Altered VPS36 expression disrupts ESCRT-mediated degradation of growth factor receptors, promoting oncogenic signaling. COSMIC; TCGA data show copy number alterations and differential expression in multiple cancer types.
Neurodegenerative disorders Impaired ESCRT function leads to accumulation of ubiquitinated proteins and autophagic dysfunction. Studies in model organisms; ClinVar reports variants of uncertain significance.
Viral infection (HIV-1) VPS36 interacts with viral Gag protein to facilitate viral budding; dysregulation may affect infectivity. Published research; UniProt annotation.

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.3 Medium
Lung 8.7 Low
Liver 6.2 Low
Kidney 9.5 Medium
Testis 15.1 High
Cell Line Expression
Cell Line nTPM Notes
HeLa 10.2 Cervical cancer cell line; moderate expression
HepG2 7.8 Liver cancer cell line; low expression
A549 9.0 Lung carcinoma; moderate expression
K562 11.5 Leukemia cell line; high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1132C>T (p.Arg378Trp) Missense 0.01% (gnomAD) May affect protein stability; ClinVar uncertain significance.
c.154G>A (p.Glu52Lys) Missense 0.005% Located in GLUE domain; potential impact on ubiquitin binding.
c.789_790del (p.Glu264fs) Frameshift Rare Predicted loss-of-function; associated with disease risk in some studies.
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations leading to truncated protein or nonsense-mediated decay, impairing ESCRT-II function.

Gain of Function (GOF)

No clear gain-of-function mutations reported; overexpression may contribute to tumor progression.

Dominant Negative (DN)

Missense mutations in the GLUE domain may interfere with complex assembly, acting in a dominant-negative manner.

Gene Ontology (GO)

• protein transport • endosomal transport
• ubiquitin binding • phosphatidylinositol binding
• ESCRT complex • multivesicular body sorting

Pathways

• ESCRT pathway
• Endosomal sorting
• Autophagy
• Cytokinesis
• Viral budding

Protein Summary

VPS36 is a 375-amino acid protein that forms part of the ESCRT-II complex, which consists of VPS36, VPS22, and VPS25. The N-terminal GLUE domain binds ubiquitin and phosphatidylinositol 3,5-bisphosphate, targeting the complex to endosomal membranes. VPS36 also interacts with ESCRT-I and ESCRT-III components to facilitate vesicle formation. It is ubiquitously expressed but enriched in testis and brain. Post-translational modifications include phosphorylation, which may regulate its function.

Related Products

Product name Cat.No. Species Gene ID
VPS36 Knockout HEK293 Cell Line EDJ-KQ10876 Human 51028 Details Get a Quote
VPS36 Knockout A-549 Cell Line EDJ-KQ38559 Human 51028 Details Get a Quote
VPS36 Knockout HCT 116 Cell Line EDJ-KQ38560 Human 51028 Details Get a Quote
VPS36 Knockout HeLa Cell Line EDJ-KQ38561 Human 51028 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: